• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性淋巴细胞白血病的临床流式细胞术检测

Clinical Flow-Cytometric Testing in Chronic Lymphocytic Leukemia.

作者信息

Salem Dalia A, Stetler-Stevenson Maryalice

机构信息

Laboratory of Pathology, CCR, NCI, NIH, Bethesda, MD, USA.

Clinical Pathology Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt.

出版信息

Methods Mol Biol. 2019;2032:311-321. doi: 10.1007/978-1-4939-9650-6_17.

DOI:10.1007/978-1-4939-9650-6_17
PMID:31522426
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8276061/
Abstract

Flow-cytometric demonstration of the typical chronic lymphocytic leukemia (CLL) immunophenotype is vital for diagnosis. CLL has a characteristic immunophenotype, expressing CD5, CD19, dim CD20, dim CD22, CD23, bright CD43, dim CD45, dim to negative CD79b, dim CD81, CD200, and dim monoclonal surface immunoglobulin. This characteristic immunophenotype allows a definitive diagnosis and the ruling out of another leukemia or lymphoma. Flow cytometry also provides important prognostic information and accurate assessment of response to therapy. Here we describe optimal specimen collection, red cell lysis, appropriate panel, cell staining, acquisition on a flow cytometer, and analysis for CLL specimens.

摘要

通过流式细胞术证明典型慢性淋巴细胞白血病(CLL)免疫表型对诊断至关重要。CLL具有特征性免疫表型,表达CD5、CD19、弱阳性CD20、弱阳性CD22、CD23、强阳性CD43、弱阳性CD45、弱阳性至阴性CD79b、弱阳性CD81、CD200以及弱阳性单克隆表面免疫球蛋白。这种特征性免疫表型有助于明确诊断并排除其他白血病或淋巴瘤。流式细胞术还可提供重要的预后信息以及对治疗反应的准确评估。在此,我们描述CLL标本的最佳样本采集、红细胞裂解、合适的抗体组合、细胞染色、流式细胞仪采集及分析方法。

相似文献

1
Clinical Flow-Cytometric Testing in Chronic Lymphocytic Leukemia.慢性淋巴细胞白血病的临床流式细胞术检测
Methods Mol Biol. 2019;2032:311-321. doi: 10.1007/978-1-4939-9650-6_17.
2
Composite mantle cell lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphoma.复合套细胞淋巴瘤和慢性淋巴细胞白血病/小淋巴细胞淋巴瘤。
Cytometry B Clin Cytom. 2018 Jan;94(1):148-150. doi: 10.1002/cyto.b.21512. Epub 2017 Feb 24.
3
Building a new score system for the diagnosis and differential diagnosis of typical CLL/SLL, atypical CLL/SLL, and MCL based on the flow cytometry immunophenotyping.基于流式细胞术免疫表型分析建立用于典型慢性淋巴细胞白血病/小淋巴细胞淋巴瘤、非典型慢性淋巴细胞白血病/小淋巴细胞淋巴瘤和套细胞淋巴瘤诊断及鉴别诊断的新评分系统。
Ann Hematol. 2025 Mar;104(3):1807-1819. doi: 10.1007/s00277-025-06231-2.
4
Pan B-cell markers are not redundant in analysis of chronic lymphocytic leukemia (CLL).泛B细胞标志物在慢性淋巴细胞白血病(CLL)分析中并非多余。
Cytometry B Clin Cytom. 2003 Nov;56(1):30-42. doi: 10.1002/cyto.b.10049.
5
Large cell lymphoma transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma. A flow cytometric analysis of seven cases.慢性淋巴细胞白血病/小淋巴细胞淋巴瘤的大细胞淋巴瘤转化。7例病例的流式细胞术分析
Am J Clin Pathol. 2001 Mar;115(3):385-95. doi: 10.1309/F5WE-K2T8-BT9D-Q56D.
6
A new score including CD43 and CD180: Increased diagnostic value for atypical chronic lymphocytic leukemia.一种包含 CD43 和 CD180 的新评分:提高了非典型慢性淋巴细胞白血病的诊断价值。
Cancer Med. 2021 Jul;10(13):4387-4396. doi: 10.1002/cam4.3983. Epub 2021 Jun 1.
7
Which Markers Should the used for Diagnostic Chronic Lymphocytic Leukemia Immunophenotyping Scoring System by Flow Cytometry?流式细胞术用于诊断慢性淋巴细胞白血病免疫表型评分系统时应使用哪些标志物?
Clin Lab. 2019 Nov 1;65(11). doi: 10.7754/Clin.Lab.2019.190316.
8
CD79b expression in B cell chronic lymphocytic leukemia: its implication for minimal residual disease detection.B细胞慢性淋巴细胞白血病中CD79b的表达:其在微小残留病检测中的意义。
Leukemia. 1999 Oct;13(10):1501-5. doi: 10.1038/sj.leu.2401511.
9
Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.467例B细胞慢性淋巴细胞增殖性疾病患者的表型异常发生率:用于微小残留病研究的特定四色染色设计基础
Leukemia. 2002 Aug;16(8):1460-9. doi: 10.1038/sj.leu.2402584.
10
Optimization and Validation of an 8-Color Single-Tube Assay for the Sensitive Detection of Minimal Residual Disease in B-Cell Chronic Lymphocytic Leukemia Detected via Flow Cytometry.用于通过流式细胞术灵敏检测B细胞慢性淋巴细胞白血病微小残留病的八色单管检测法的优化与验证
Lab Med. 2016 May;47(2):103-11. doi: 10.1093/labmed/lmw006.

引用本文的文献

1
Beyond the Limits: How Is Spectral Flow Cytometry Reshaping the Clinical Landscape and What Is Coming Next?突破极限:光谱流式细胞术如何重塑临床格局以及接下来会怎样?
Cells. 2025 Jun 30;14(13):997. doi: 10.3390/cells14130997.
2
Clinical Validation and Post-Implementation Performance Monitoring of a Neural Network-Assisted Approach for Detecting Chronic Lymphocytic Leukemia Minimal Residual Disease by Flow Cytometry.用于通过流式细胞术检测慢性淋巴细胞白血病微小残留病的神经网络辅助方法的临床验证及实施后性能监测
Cancers (Basel). 2025 May 17;17(10):1688. doi: 10.3390/cancers17101688.
3
Flow Cytometry for B-Cell Non-Hodgkin and Hodgkin Lymphomas.

本文引用的文献

1
Validation of three viable-cell counting methods: Manual, semi-automated, and automated.三种活细胞计数方法的验证:手动、半自动和自动方法。
Biotechnol Rep (Amst). 2015 Apr 18;7:9-16. doi: 10.1016/j.btre.2015.04.004. eCollection 2015 Sep.
2
CD49d shows superior performance characteristics for flow cytometric prognostic testing in chronic lymphocytic leukemia/small lymphocytic lymphoma.CD49d 在慢性淋巴细胞白血病/小淋巴细胞淋巴瘤的流式细胞术预后检测中具有优越的性能特征。
Cytometry B Clin Cytom. 2018 Jan;94(1):129-135. doi: 10.1002/cyto.b.21384. Epub 2016 Jun 27.
3
CD49d is the strongest flow cytometry-based predictor of overall survival in chronic lymphocytic leukemia.
B细胞非霍奇金淋巴瘤和霍奇金淋巴瘤的流式细胞术
Cancers (Basel). 2025 Feb 26;17(5):814. doi: 10.3390/cancers17050814.
4
Ligands of CD6: roles in the pathogenesis and treatment of cancer.CD6的配体:在癌症发病机制和治疗中的作用
Front Immunol. 2025 Jan 7;15:1528478. doi: 10.3389/fimmu.2024.1528478. eCollection 2024.
5
Current Status of Flow Cytometric Immunophenotyping of Hematolymphoid Neoplasms in Korea.韩国血液淋巴肿瘤流式细胞免疫表型分析的现状。
Ann Lab Med. 2024 May 1;44(3):222-234. doi: 10.3343/alm.2023.0298. Epub 2023 Dec 26.
6
The inhibitory receptor Siglec-G controls the severity of chronic lymphocytic leukemia.抑制性受体 Siglec-G 控制慢性淋巴细胞白血病的严重程度。
EMBO Rep. 2023 Aug 3;24(8):e56420. doi: 10.15252/embr.202256420. Epub 2023 Jul 10.
7
Targeting of Tetraspanin CD81 with Monoclonal Antibodies and Small Molecules to Combat Cancers and Viral Diseases.利用单克隆抗体和小分子靶向四跨膜蛋白CD81以对抗癌症和病毒性疾病
Cancers (Basel). 2023 Apr 6;15(7):2186. doi: 10.3390/cancers15072186.
8
Measurable residual disease in chronic lymphocytic leukemia.慢性淋巴细胞白血病中的可测量残留病灶
Front Oncol. 2023 Feb 14;13:1112616. doi: 10.3389/fonc.2023.1112616. eCollection 2023.
9
ALK-Positive Anaplastic Large-Cell Lymphoma in a Patient with Chronic Lymphocytic Leukemia: A Case Report and Literature Review.慢性淋巴细胞白血病患者中的ALK阳性间变性大细胞淋巴瘤:一例报告及文献综述
Onco Targets Ther. 2022 Oct 19;15:1245-1253. doi: 10.2147/OTT.S383779. eCollection 2022.
10
Implementation of International Prognostic Index with flow cytometry immunophenotyping for better risk stratification of chronic lymphocytic leukemia.采用流式细胞免疫表型分析实施国际预后指数,以更好地对慢性淋巴细胞白血病进行风险分层。
Eur J Haematol. 2022 Nov;109(5):483-493. doi: 10.1111/ejh.13833. Epub 2022 Aug 1.
CD49d 是慢性淋巴细胞白血病中基于流式细胞术的最强总生存预测因子。
J Clin Oncol. 2014 Mar 20;32(9):897-904. doi: 10.1200/JCO.2013.50.8515. Epub 2014 Feb 10.
4
Implications of new prognostic markers in chronic lymphocytic leukemia.新预后标志物在慢性淋巴细胞白血病中的意义。
Hematology Am Soc Hematol Educ Program. 2012;2012:76-87. doi: 10.1182/asheducation-2012.1.76.
5
Improving efficiency and sensitivity: European Research Initiative in CLL (ERIC) update on the international harmonised approach for flow cytometric residual disease monitoring in CLL.提高效率和灵敏度:慢性淋巴细胞白血病(CLL)欧洲研究倡议(ERIC)关于国际协调流式细胞术残留疾病监测方法在 CLL 中的更新。
Leukemia. 2013 Jan;27(1):142-9. doi: 10.1038/leu.2012.216. Epub 2012 Jul 31.
6
Diagnostic usefulness and prognostic impact of CD200 expression in lymphoid malignancies and plasma cell myeloma.CD200 表达在淋巴恶性肿瘤和浆细胞骨髓瘤中的诊断意义和预后影响。
Am J Clin Pathol. 2012 Jan;137(1):93-100. doi: 10.1309/AJCP59UORCYZEVQO.
7
Immunophenotypic features distinguishing familial chronic lymphocytic leukemia from sporadic chronic lymphocytic leukemia.区分家族性慢性淋巴细胞白血病与散发性慢性淋巴细胞白血病的免疫表型特征。
Cytometry B Clin Cytom. 2008 Jul;74(4):221-6. doi: 10.1002/cyto.b.20423.
8
Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemia.CD49d蛋白表达作为慢性淋巴细胞白血病总生存期和疾病进展预后指标的相关性
Blood. 2008 Jan 15;111(2):865-73. doi: 10.1182/blood-2007-05-092486. Epub 2007 Oct 24.
9
International standardized approach for flow cytometric residual disease monitoring in chronic lymphocytic leukaemia.慢性淋巴细胞白血病流式细胞术残留病监测的国际标准化方法
Leukemia. 2007 May;21(5):956-64. doi: 10.1038/sj.leu.2404584. Epub 2007 Mar 15.
10
Diagnostic criteria for monoclonal B-cell lymphocytosis.单克隆B淋巴细胞增多症的诊断标准。
Br J Haematol. 2005 Aug;130(3):325-32. doi: 10.1111/j.1365-2141.2005.05550.x.